Product Information
Name:MPT0B098
Brand:Biosynth
Description:MPT0B098 is a drug candidate that inhibits actin polymerization. This drug has been shown to reduce tumor growth and vascular density in animal models, which may be due to its ability to destabilize the cytoskeleton of cancer cells. MPT0B098 also inhibits the production of epidermal growth factor (EGF) in fetal bovine serum and may be a potential drug target for EGF-dependent cancers. The mechanism of action for MPT0B098 is not yet clear. It binds to the α subunit of actin filaments and could potentially stabilize or destabilize them, depending on the binding site. It has been shown to interfere with the logarithmic growth phase in some cell lines, but not others. MPT0B098 has been shown to induce monoclonal antibodies in mice and rabbits.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:366.4 g/mol
Formula:C20H18N2O3S
Purity:Min. 95%
Color/Form:Powder
Technical inquiry about: MPT0B098
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.